Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 52,619 shares at $122.66 ($6.5M) on 2025-05-15, disclosed to the SEC on 2025-05-16.
Scheduled sale ($6.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.66 | 2,043 | $251K | 3.9% |
| 2 | $122.66 | 2,043 | $251K | 3.9% |
| 3 | $123.57 | 17,596 | $2.2M | 33.4% |
| 4 | $123.57 | 17,596 | $2.2M | 33.4% |
| 5 | $124.34 | 6,533 | $812K | 12.5% |
| 6 | $124.34 | 6,533 |
| $812K |
| 12.5% |
| 7 | $125.20 | 268 | $34K | 0.5% |
| 8 | $127.00 | 7 | $889 | 0.0% |
| Total | $123.70 avg | 52,619 | $6.5M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |
| RGEN | SELL | 2024-11-22 | $6.8M | — | Filing → |